Evidence map›Paper›PMID 36314806›Full record

ArticleJournal of clinical microbiology2022

Analytical Sensitivity of Lateral Flow Devices against SARS-CoV-2 Omicron Subvariants BA.4, BA.5, and BA.2.75.

Charlene Mackenzie, Mitchell Batty, Georgina Papadakis, Laura Stevens, Yano Yoga, George Taiaroa, Helen Stefanatos, Ivana Savic, Thomas Tran, Joshua Deerain and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Charlene MackenzieVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Mitchell BattyVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.ORCID 0000-0003-1825-5629
Georgina PapadakisVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Laura StevensVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Yano YogaVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
George TaiaroaDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Helen StefanatosDepartment of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Ivana SavicVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Thomas TranVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Joshua DeerainVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Jacqueline PrestedgeVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Julian DruceVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Leon CalyVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
Deborah A WilliamsonVictorian Infectious Diseases Reference Laboratorygrid.433799.3, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Victoria, Australia.ORCID 0000-0001-7363-6665

Funding

Department of Health | National Health and Medical Research Council (NHMRC) APP1174555Department of Health | National Health and Medical Research Council (NHMRC) APP2002317
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralCell LineHumansAntibodies, Viralantigen testsCOVID-19SARS-CoV-2

Identifiers

PMID36314806
PMCPMC9667757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.